Skip to main content

Share story

Science Security

Three-user quantum-key experiment withstands 59.6 dB system loss

Three-user quantum-key experiment withstands 59.6 dB system loss Image: Primary
Researchers at Nanjing University experimentally generated a shared secure key for three users under total system loss of approximately 59.6 dB, compared with approximately 21.5 dB in the group's earlier measurement-device-independent conferencing experiment. The laboratory result was published in Physical Review Letters. The protocol pairs single-photon detections recorded at different times instead of requiring simultaneous multiphoton events, improving how key rates scale as users and transmission losses increase. A shared measurement station can announce detections without being trusted. At the highest tested loss, however, the secure-key rate was approximately 4.470 × 10⁻⁹ bits per pulse, and practical intercity deployment remains future work.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Phys.org and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...